General Counsel, Vice President Intellectual Property, NetBio, Inc.
Chairman and CEO, BlinkBio
Executive Director, Program Direction, Immunology & Inflammation, Regeneron Pharmaceuticals, Inc.
Presidential Professor of Medicinal Chemistry and Research Professor of Biochemistry, The University of Utah
Vice President, Preclinical Development, Medivation, Inc.
Distinguished Professor and Chair, Department of Biomedical Engineering, Stony Brook University; Director, Center for Biotechnology
Chief Executive Officer, Orthobond Corporation
Director of Patents and Licensing, New York Blood Center and LF Kimball Research Institute (Retired)
Professor and Chairman,
Department of Surgery,
Stony Brook University School of Medicine
Distinguished Professor and Director
Dr. Rubin is a fellow of the American Institute of Biological and Medical Engineers, and a recipient of the Presidential Young Investigator Award from the National Science Foundation, two Kappa Delta Awards from the American Academy of Orthopaedic Surgeons, the John Charnley Award from the Hip Society, the Fuller Albright Award from the American Society of Bone and Mineral Research, and the Giovanni Borelli Award from the American Society of Biomechanics.
Dr. Rubin’s work is targeted towards understanding the cellular mechanisms responsible for the growth, healing, and homeostasis of bone. This work focuses on how biophysical stimuli (i.e., mechanical, electrical, temperature, magnetic, pressure) mediate these responses through the control of mesenchymal stem cell differentiation and proliferation.
Dr. Rubin is currently funded by NIH, NASA, the Whitaker Foundation, private industry and the New York State Foundation for Science, Technology and Innovation. Dr. Rubin holds twenty-two patents, with fourteen pending, in the area of wound repair, stem cell regulation, and treatment of bone disease. Dr. Rubin is a founder of Exogen, Inc., now a subsidiary of Smith + Nephew, Inc., Juvent, Inc., a start-up focusing on osteoporosis treatment and Marodyne Medical, a medical device company utilizing biophysical stimuli to treat human injury and disease.
Dr. Rubin earned his BA in Physiology from Harvard University and his PhD in Anatomy from the University of Bristol, England. He held positions at Tufts University and Brigham & Women’s Hospital in Boston before coming to Stony Brook University in 1987.
Ms. Fabel has primary responsibility for the financing and management of daily operations, and has played a critical role in shaping the strategic direction of the CFB. She serves as a liaison between the bioscience industry, the CFB and the academic community in the establishment of research collaborations, new product development, company formations, and other forms of economic impact.
Ms. Fabel’s extensive experience in the development of programs to support company start-ups is vital to the CAT’s Technology Development Initiative. Ms. Fabel played a strategic role in the development of the New York Biotechnology Association and the Long Island High Technology Incubator program. Ms. Fabel received her M.S. degree in technology management from SUNY Stony Brook.
Assistant Director, Technology and Business Development
Dr. Liu joined CFB as a Technology Commercialization Fellow in September 2012 and became Manager, Technology and Business Development in the Spring 2014. In Fall 2016, he became Assistant Director, Technology and Business Development. He is actively engaged with early-stage biotechnology companies to identify and address critical business issues, driving the technology a step closer to the commercialization. In addition, he is also responsible for the corporate outreach and operation of the monthly biostrategy session, while overseeing student teams from the college of business and Fundamental of Bioscience Industry program at Stony Brook University.
Dr. Liu received his B.S. in Chemistry from Fudan University (China, 2007) and Ph.D. in Chemistry from Stony Brook University (2012). He is also a CFA level III candidate (2013) and alumni of Fundamentals of the Biosciences Industry Program. Prior to joining the Center he completed an internship at Ascent Biomedical Ventures conducting due diligence on investment opportunities.
Assistant Director, Outreach & Programs
Ms. Hutchinson is responsible for the management and implementation of the CFB’s events, programs and communications. She leads the planning, development and execution of major CFB initiatives including the annual Life Sciences Summit as well as the CFB’s cornerstone workforce development program, the Fundamentals of the Bioscience Industry program.
In addition to her program and event roles, Ms. Hutchinson also is responsible for the communication needs of the CFB. In this role, she develops, maintains and executes the varied communication mediums employed by the CFB. Ms. Hutchinson has also developed and designed many of the CFB’s promotional pieces.
Ms. Hutchinson received her Bachelor of Arts Degree in Communication from the University of Delaware and her Master’s Degree from Stony Brook University. She holds certifications in Graphic Design from Hofstra University and Website Design from Stony Brook University.
Senior Manager, Finance and Grants Administration
Kris Duryea is responsible for the daily financial administration of the Center and its various programs and activities. She is also responsible for personnel actions and coordinating reporting requirements. Her background includes over 20 years in Research Administration at Stony Brook University, Brookhaven National Laboratory and the University of North Carolina at Charlotte.
Kris has an M.A. in Business and Policy Studies from Empire State University, a Graduate Certificate in Research Administration from Emmanuel College, and is a Certified Research Administrator.
Technology Commercialization Fellow
Bill joined the Center for Biotechnology as a Technology Commercialization Fellow in 2015. He actively engages with early technologies, often at the ideation stage, to identify possible markets and business issues. He provides strategic consulting, business development and technology commercialization services to biomedical companies throughout New York and Long Island. He also performs due diligence to support administration of NIH Research Evaluation and Commercialization Hub (REACH) funding.
Bill brings a broad research background to his role. He performed his doctoral thesis work at the Feinstein Institute for Medical Research, part of Northwell Health (North Shore-LIJ) under Kevin Tracey, where he studied the interaction of the brain and the immune system, and discovered a novel reflex. His previous research experience includes Rockefeller University, the Uniformed Services University for the Health Science, Miami University, and Mannkind Corporation.
Before returning to graduate school, Bill practiced as a patent attorney, focused on biotechnology and medical devices.
Bill received a B.A. in Microbiology from Miami University, a J.D. from Benjamin N. Cardozo School of Law, and a Ph.D. from Stony Brook University. He is licensed to practice in New York, Colorado, and before the US Patent and Trademark office.
Ms. Allegretti provides diverse administrative and project support in the development and execution of all Center programs and activities. She interacts with senior executives, management and operations staff.
Her background includes over 8 years experience as the Operations & Social Media Coordinator at Long Island Forum for Technology (LIFT). Julie serves as the Co-Vice President of the Social Media Association (SMA). This organization fosters collaborations with industry professionals.
Julie holds a BS in Security Systems, AS in Criminal Justice, and AS in Liberal Arts and Sciences from Farmingdale State College. She was a founding member and treasurer of the National Criminal Justice Honor Society. She was named in the 2015 Huntington Township Chamber of Commerce “Celebrate Long Island’s Young Professionals” 30 Under 30 Award for making a notable impact on local businesses, industry and community. In 2016, she was awarded the honor of Excellence in Communication in the area of In-House Marketing Professional from the Long Island Business News.